Works by Witzig, Thomas

Results: 231
    1
    2

    Heavy chain disease.

    Published in:
    2002
    By:
    • Witzig, Thomas;
    • Roedler, Dietlind;
    • Witzig, Thomas E;
    • Wahner-Roedler, Dietlind L
    Publication type:
    journal article
    3

    Depth of Response From Fixed‐Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 6, p. 980, doi. 10.1002/ajh.27663
    By:
    • Paludo, Jonas;
    • Abeykoon, Jithma P.;
    • Perera, Nirosha D.;
    • Sarosiek, Shayna;
    • Gustine, Joshua;
    • Ramirez‐Gamero, Andres;
    • Varettoni, Marzia;
    • Tedeschi, Alessandra;
    • Cavalloni, Chiara;
    • Frustaci, Anna Maria;
    • Pederson, Levi D.;
    • Zanwar, Saurabh S.;
    • Kapoor, Prashant;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Geyer, Susan M.;
    • Treon, Steven P.;
    • Castillo, Jorge J.
    Publication type:
    Article
    4
    5
    6
    7
    8

    PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
    By:
    • Desai, Sanjal H.;
    • Pederson, Levi;
    • LaPlant, Betsy;
    • Mwangi, Raphael;
    • Maurer, Matthew;
    • Young, Jason R.;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Cerhan, James R.;
    • Feldman, Andrew;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    9
    10

    Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
    By:
    • Desai, Sanjal H.;
    • LaPlant, Betsy;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    11

    Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
    By:
    • Arushi Khurana;
    • Mwangi, Raphael;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Strouse, Christopher;
    • Link, Brian K.;
    • Wang, Yucai;
    • King, Rebecca L.;
    • Macon, William R.;
    • Villasboas, J. C.;
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    12

    Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00452-0
    By:
    • Gile, Jennifer J.;
    • Lopez, Camden L.;
    • Ruan, Gordon J.;
    • Hathcock, Matthew A.;
    • Abeykoon, Jithma P.;
    • Heimgartner, Joy R.;
    • Baumann, Nikola A.;
    • McMahon, M. Molly;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Bisneto, Jose C. Villasboas;
    • Porrata, Luis F.;
    • Paludo, Jonas;
    • Ansell, Stephen M.;
    • Hogan, William J.;
    • Witzig, Thomas E.
    Publication type:
    Article
    13
    14
    15

    Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
    By:
    • Wang, Yucai;
    • Wenzl, Kerstin;
    • Manske, Michelle K.;
    • Asmann, Yan W.;
    • Sarangi, Vivekananda;
    • Greipp, Patricia T.;
    • Krull, Jordan E.;
    • Hartert, Keenan;
    • He, Rong;
    • Feldman, Andrew L.;
    • Maurer, Matthew J.;
    • Slager, Susan L.;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Link, Brian K.;
    • Ansell, Stephen M.;
    • Cerhan, James R.;
    • Novak, Anne J.
    Publication type:
    Article
    16
    17
    18

    Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.

    Published in:
    International Journal of Dermatology, 2002, v. 41, n. 6, p. 352, doi. 10.1111/j.1365-4632.2002.01501.x
    By:
    • Bouwhuis, Saskia A.;
    • el-Azhary, Rokea A.;
    • McEvoy, Marian T.;
    • Gibson, Lawrence E.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Pittelkow, Mark R.
    Publication type:
    Article
    19
    20
    21
    22
    23

    Central nervous system involvement by mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 2, p. 371, doi. 10.1080/10428194.2022.2148211
    By:
    • McLaughlin, Nicole;
    • Wang, Yucai;
    • Witzig, Thomas;
    • Villasboas, Jose;
    • Habermann, Thomas;
    • Inwards, David;
    • Bennani, Nora;
    • Thanarajasingam, Gita;
    • Nowakowski, Grzegorz;
    • Porrata, Luis;
    • Thompson, Carrie;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Ansell, Stephen;
    • Paludo, Jonas
    Publication type:
    Article
    24
    25

    PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 12, p. 2816, doi. 10.1080/10428194.2022.2095624
    By:
    • Broglio, Kristine;
    • Kostakoglu, Lale;
    • Ward, Carol;
    • Mattiello, Federico;
    • Sahin, Denis;
    • Nielsen, Tina;
    • McGlothlin, Anna;
    • Elliott, Corrine F.;
    • Witzig, Thomas;
    • Sehn, Laurie H.;
    • Trnĕný, Marek;
    • Vitolo, Umberto;
    • Martelli, Maurizio;
    • Foster, Margaret;
    • Wendelberger, Barbara;
    • Nowakowski, Grzegorz;
    • Berry, Donald A.
    Publication type:
    Article
    26

    Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 2, p. 308, doi. 10.1080/10428194.2020.1832669
    By:
    • Gunaratne, Madugodaralalage D. S. K.;
    • Sahakian, Alexander J.;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Kapoor, Prashant;
    • Paulus, Aneel;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Novak, Anne J.;
    • Lacy, Martha Q.;
    • Kyle, Robert A.;
    • Go, Ronald S.;
    • Paludo, Jonas
    Publication type:
    Article
    27
    28
    29
    30

    Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2712, doi. 10.1080/10428194.2019.1602268
    By:
    • Hampel, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Witzig, Thomas E.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    31

    A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 9, p. 2128, doi. 10.1080/10428194.2017.1416368
    By:
    • Sonbol, Mohamad Bassam;
    • Hilal, Talal;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Northfelt, Donald W.;
    • Bergsagel, Peter Leif;
    • Reeder, Craig B.;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Conley, Christopher R.;
    • Gano, Katherine M.;
    • Nichols, Craig S.;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.
    Publication type:
    Article
    32
    33
    34

    Survival in patients with limited-stage peripheral T-cell lymphomas.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1665, doi. 10.3109/10428194.2014.963078
    By:
    • Briski, Robert;
    • Feldman, Andrew L.;
    • Bailey, Nathaniel G.;
    • Lim, Megan S.;
    • Ristow, Kay;
    • Habermann, Thomas M.;
    • Macon, William R.;
    • Inwards, David J.;
    • Colgan, Joseph P.;
    • Nowakowski, Grzegorz S.;
    • Kaminski, Mark S.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Wilcox, Ryan A.
    Publication type:
    Article
    35

    Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2014, v. 55, n. 12, p. 2728, doi. 10.3109/10428194.2014.893313
    By:
    • Porrata, Luis F.;
    • Ristow, Kay M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Nowakowski, Grzegorz;
    • Thompson, Carrie A.;
    • Markovic, Svetomir N.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.

    Published in:
    Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1475, doi. 10.1007/s00262-013-1452-4
    By:
    • Charbonneau, Bridget;
    • Wang, Alice;
    • Maurer, Matthew;
    • Asmann, Yan;
    • Zent, Clive;
    • Link, Brian;
    • Ansell, Stephen;
    • Weiner, George;
    • Ozsan, Nazan;
    • Feldman, Andrew;
    • Witzig, Thomas;
    • Cunningham, Julie;
    • Dogan, Ahmet;
    • Habermann, Thomas;
    • Slager, Susan;
    • Novak, Anne;
    • Cerhan, James
    Publication type:
    Article
    42

    Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical Pilot.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 2, p. 218, doi. 10.1002/ajh.27533
    By:
    • Witzig, Thomas E.;
    • Taylor, William R.;
    • Mahoney, Douglas W.;
    • Bamlet, William R.;
    • Foote, Patrick H.;
    • Burger, Kelli N.;
    • Doering, Karen A.;
    • Devens, Mary E.;
    • Arndt, Jacquelyn R.;
    • O'Connell, Maria C.;
    • Berger, Calise K.;
    • Novak, Anne J.;
    • Cerhan, James R.;
    • Hennek, Jacquelyn;
    • Katerov, Slava;
    • Allawi, Hatim T.;
    • Jevremovic, Dragan;
    • Dao, Linda N.;
    • Graham, Rondell P.;
    • Kisiel, John B.
    Publication type:
    Article
    43
    44

    The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 3, p. 408, doi. 10.1002/ajh.27202
    By:
    • Cerhan, James R.;
    • Maurer, Matthew J.;
    • Link, Brian K.;
    • Feldman, Andrew L.;
    • Habermann, Thomas M.;
    • Jaye, David L.;
    • Burack, W. Richard;
    • McDonnell, Timothy J.;
    • Vega, Francisco;
    • Chapman, Jennifer R.;
    • Syrbu, Sergei;
    • Vij, Kiran R.;
    • Inghirami, Giorgio;
    • Leonard, John P.;
    • Bernal‐Mizrachi, Leon;
    • Farooq, Umar;
    • Witzig, Thomas E.;
    • Weiner, George J.;
    • Wang, Yucai;
    • Alderuccio, Juan P.
    Publication type:
    Article
    45

    Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
    By:
    • Chohan, Karan L.;
    • Paludo, Jonas;
    • Vallumsetla, Nishanth;
    • Larson, Dirk;
    • King, Rebecca L.;
    • He, Rong;
    • Gonsalves, Wilson;
    • Inwards, David;
    • Witzig, Thomas E.;
    • Swaika, Abhisek;
    • Jain, Tania;
    • Leung, Nelson;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Ansell, Stephen M.
    Publication type:
    Article
    46

    Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003–2018).

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1150, doi. 10.1002/ajh.26635
    By:
    • Seegobin, Karan;
    • Li, Zhuo;
    • Alhaj Moustafa, Muhamad;
    • Majeed, Umair;
    • Wang, Jing;
    • Jiang, Liuyan;
    • Kuhlman, Justin;
    • Menke, David;
    • Li, Ke;
    • Kharfan‐Dabaja, Mohamed A.;
    • Ayala, Ernesto;
    • Iqbal, Madiha;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Johnston, Patrick;
    • Thompson, Carrie;
    • Ansell, Stephen;
    • Tun, Han W.
    Publication type:
    Article
    47

    Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 979, doi. 10.1002/ajh.26230
    By:
    • Boddicker, Nicholas J.;
    • Larson, Melissa C.;
    • Castellino, Alessia;
    • Herrmann, Joerg;
    • Inwards, David J.;
    • Thanarajasingam, Gita;
    • Maurer, Matthew J.;
    • Allmer, Cristine;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Villarraga, Hector R.;
    • Slager, Susan L.;
    • Cerhan, James R.;
    • Thompson, Carrie A.
    Publication type:
    Article
    48

    Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy T.;
    • Habermann, Thomas M.;
    • Inwards, David;
    • Go, Ronald S.;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    49

    Testicular FDG‐PET/CT uptake threshold in aggressive lymphomas.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 3, p. E81, doi. 10.1002/ajh.26073
    By:
    • Higgins, Alexandra;
    • Kim, Hidong;
    • Harper, Laura;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.;
    • Thompson, Carrie A.;
    • Johnston, Patrick;
    • Witzig, Thomas E.;
    • Allmer, Cristine;
    • Maurer, Matthew J.;
    • Cerhan, James R.;
    • Young, Jason R.;
    • Thanarajasingam, Gita
    Publication type:
    Article
    50

    Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. E57, doi. 10.1002/ajh.25690
    By:
    • Hampel, Paul J.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Muchtar, Eli;
    • Kenderian, Saad S.;
    • Wang, Yucai;
    • Leis, Jose F.;
    • Witzig, Thomas E.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Rabe, Kari G.;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article